文献速递胃肠外科肝胆胰外科

腹腔镜D2全胃切除联合脾胰体尾整块切除治疗局部进展期近端胃癌

Laparoscopic D2 total gastrectomy and en-mass splenectomy and distal pancreatectomy for locally advanced proximal gastric cancer.
PubMed 文献 · Surg Endosc · 2017-08-25

本文报告一例64岁女性近端胃腺癌(靠近贲门食管交界)侵犯胰尾,行腹腔镜D2全胃切除联合脾切除及远端胰腺整块切除。手术总时间235分钟,术后第7天经造影和蓝染试验确认无吻合口漏后开始经口进食,第9天出院。组织学为低分化腺癌,pT3N3b(62枚淋巴结中17枚阳性)。作者认为该术式可行且安全,但肿瘤学价值尚待确定。

要点

  • 腹腔镜D2全胃切除联合脾胰体尾整块切除在局部进展期近端胃癌中可行且安全。
  • 术后第7天经造影和蓝染试验确认无吻合口漏后开始经口进食,第9天出院。
  • 组织学为低分化腺癌,pT3N3b(62枚淋巴结中17枚阳性)。

核心结论

  • 腹腔镜D2全胃切除联合脾及远端胰腺整块切除在进展期胃癌中可行且安全,但肿瘤学价值尚未确定。

研究设计与样本

  • 病例报告:一例64岁女性近端胃腺癌(靠近贲门食管交界)侵犯胰尾,行腹腔镜D2全胃切除联合脾切除及远端胰腺整块切除。

主要发现

  • 总手术时间235分钟。
  • 术后第7天胃造影试验和蓝染试验均显示无吻合口漏,开始经口进食,第9天出院。
  • 组织学为低分化腺癌,pT3N3b(62枚淋巴结中17枚阳性)。

临床怎么用

  • 对于局部进展期近端胃癌侵犯胰尾者,可考虑腹腔镜D2全胃切除联合脾及远端胰腺整块切除。

局限性

  • 单例病例报告,腹腔镜手术在局部进展期胃癌中的安全性和疗效尚未经随机对照试验证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Safety and efficacy of laparoscopy surgery in locally Advanced Gastric Cancers (AGC) have not been proven by randomized control trials. Therefore, standard of care for AGC is still open surgery. Here, we are presenting a 64-year-old female with proximal gastric adenocarcinoma (close to cardio-oesophageal junction) adherent to tail of pancreas, who underwent D2 total gastrectomy en-mass distal pancreatectomy and splenectomy. METHODS: Five ports are entered into the peritoneal cavity (Three 10-12 mm and two 5 mm ports). Another 5 mm stab incision is made in the epigastrium for Nathanson Liver retractor. Standard D2 Gastrectomy was performed with en-mass removal of the spleen and body and tail of the pancreas. Roux-en-Y oesophago-jejunostomy (Hand sewn) and Jejuno-Jejunostomy reconstruction were performed laparoscopically. Hereby, we present a video of the above procedure. RESULTS: Total Operating time was 235 min. Post-operatively the patient was able to mobilize independently. Total Parenteral Nutrition (TPN) was started and continued until post-operative day (POD) 7 once gastrografin test and blue dye test both showed no anastomotic leak. Patient started on oral feeding and was discharged home well on POD 9. Histology showed poorly differentiated adenocarcinoma with pT3N3b (17 nodes out of 62 positive). CONCLUSION: Although laparoscopic D2 gastrectomy and en-mass distal pancreatectomy and splenectomy are feasible and safe in advanced gastric carcinoma, its oncological value has yet to be determined.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Toh BC, Rao J. Laparoscopic D2 total gastrectomy and en-mass splenectomy and distal pancreatectomy for locally advanced proximal gastric cancer. Surg Endosc. 2017. PMID: 28842726. doi:10.1007/s00464-017-5801-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。